Hypertensive Emergency: Parenteral Antihypertensives and Population Data
AbstractPurpose of ReviewReview parenteral therapeutic choices in treatment of hypertensive crises by mechanism of action and summarize recent literature on the management of hypertensive crises.Recent FindingsRecent data have documented the safety and efficacy of labetalol and nicardipine in treatment of hypertensive crises as well as characterized the hypertensive emergency population to a much greater extent.SummaryBased on recent data, hypertensive emergencies are seen in 0.5% of all emergency room visits. Ischemic stroke and heart failure/pulmonary edema are the most common forms of organ damage seen in hypertensive e...
Source: Current Hypertension Reports - December 1, 2023 Category: Primary Care Source Type: research
Physiologic Treatment of Severe Hypertension in Pregnancy and Postpartum
Obstet Gynecol. 2023 Nov 30. doi: 10.1097/AOG.0000000000005472. Online ahead of print.ABSTRACTWe aimed to evaluate physiologic treatment of severe hypertension. This was a retrospective cohort study of pregnant and postpartum patients with severe hypertension (systolic blood pressure [BP] 160 mm Hg or higher or diastolic BP 110 mm Hg or higher) treated with intravenous labetalol or hydralazine at a single tertiary care center between 2013 and 2018. Patients were classified as having physiologic treatment if they had hyperdynamic physiology (pulse pressure 65 mm Hg or higher) and received labetalol or had vasoconstrictive p...
Source: Obstetrics and Gynecology - November 30, 2023 Category: OBGYN Authors: Allison M Davis Christina T Blanchard Akila Subramaniam Rachel G Sinkey Alan T Tita Ashley N Battarbee Source Type: research
Physiologic Treatment of Severe Hypertension in Pregnancy and Postpartum
Obstet Gynecol. 2023 Nov 30. doi: 10.1097/AOG.0000000000005472. Online ahead of print.ABSTRACTWe aimed to evaluate physiologic treatment of severe hypertension. This was a retrospective cohort study of pregnant and postpartum patients with severe hypertension (systolic blood pressure [BP] 160 mm Hg or higher or diastolic BP 110 mm Hg or higher) treated with intravenous labetalol or hydralazine at a single tertiary care center between 2013 and 2018. Patients were classified as having physiologic treatment if they had hyperdynamic physiology (pulse pressure 65 mm Hg or higher) and received labetalol or had vasoconstrictive p...
Source: Obstetrics and Gynecology - November 30, 2023 Category: OBGYN Authors: Allison M Davis Christina T Blanchard Akila Subramaniam Rachel G Sinkey Alan T Tita Ashley N Battarbee Source Type: research
Physiologic Treatment of Severe Hypertension in Pregnancy and Postpartum
Obstet Gynecol. 2023 Nov 30. doi: 10.1097/AOG.0000000000005472. Online ahead of print.ABSTRACTWe aimed to evaluate physiologic treatment of severe hypertension. This was a retrospective cohort study of pregnant and postpartum patients with severe hypertension (systolic blood pressure [BP] 160 mm Hg or higher or diastolic BP 110 mm Hg or higher) treated with intravenous labetalol or hydralazine at a single tertiary care center between 2013 and 2018. Patients were classified as having physiologic treatment if they had hyperdynamic physiology (pulse pressure 65 mm Hg or higher) and received labetalol or had vasoconstrictive p...
Source: Obstetrics and Gynecology - November 30, 2023 Category: OBGYN Authors: Allison M Davis Christina T Blanchard Akila Subramaniam Rachel G Sinkey Alan T Tita Ashley N Battarbee Source Type: research
Physiologic Treatment of Severe Hypertension in Pregnancy and Postpartum
Obstet Gynecol. 2023 Nov 30. doi: 10.1097/AOG.0000000000005472. Online ahead of print.ABSTRACTWe aimed to evaluate physiologic treatment of severe hypertension. This was a retrospective cohort study of pregnant and postpartum patients with severe hypertension (systolic blood pressure [BP] 160 mm Hg or higher or diastolic BP 110 mm Hg or higher) treated with intravenous labetalol or hydralazine at a single tertiary care center between 2013 and 2018. Patients were classified as having physiologic treatment if they had hyperdynamic physiology (pulse pressure 65 mm Hg or higher) and received labetalol or had vasoconstrictive p...
Source: Obstetrics and Gynecology - November 30, 2023 Category: OBGYN Authors: Allison M Davis Christina T Blanchard Akila Subramaniam Rachel G Sinkey Alan T Tita Ashley N Battarbee Source Type: research
